Evidence map›Paper›PMID 29197068›Full record

ArticleInternational journal of cancer2018

Drivers of advanced stage at breast cancer diagnosis in the multicountry African breast cancer - disparities in outcomes (ABC-DO) study.

Fiona McKenzie, Annelle Zietsman, Moses Galukande, Angelica Anele, Charles Adisa, Groesbeck Parham, Leeya Pinder, Herbert Cubasch, Maureen Joffe, Frederick Kidaaga and 8 more

Abstract read
In one paragraph

Article in International journal of cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Fiona McKenzieSection of Environment and Radiation, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-0790-1752
Annelle ZietsmanWindhoek Central Hospital, Windhoek, Namibia.
Moses GalukandeMakerere University, Kampala, Uganda.
Angelica AneleFederal Medical Centre, Owerri, Nigeria.
Charles AdisaAbia State University Teaching Hospital, Aba, Nigeria.
Groesbeck ParhamUniversity of North Carolina, Chapel Hill, USA.
Leeya PinderUniversity of North Carolina, Chapel Hill, USA.
Herbert CubaschUniversity of the Witwatersrand, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
Maureen JoffeUniversity of the Witwatersrand, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
Frederick KidaagaNamibian Institute of Pathology, Windhoek, Namibia.
Robert LukandeMakerere University, Kampala, Uganda.
Awa U OffiahAbia State University Teaching Hospital, Aba, Nigeria.
Ralph O EgejuruFederal Medical Centre, Owerri, Nigeria.
Aaron ShibembaUniversity Teaching Hospital, Lusaka, Zambia.
Joachim SchuzSection of Environment and Radiation, International Agency for Research on Cancer, Lyon, France.
Benjamin O AndersonFred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Isabel Dos Santos SilvaDepartment of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Valerie McCormackSection of Environment and Radiation, International Agency for Research on Cancer, Lyon, France.

Funding

HIV's Effects on Breast Cancer Treatment and Outcomes in South AfricaR01CA192627 · NCI · WITS HEALTH CONSORTIUM (PTY), LTD · PI JACOBSON, JUDITH S, JOFFE, MAUREEN · 2015 to 2019
$1.7M
NCI NIH HHS R01 CA192627World Health Organization 001
6 · The paper itself

Abstract

Breast cancer (BC) survival rates in sub-Saharan Africa (SSA) are low in part due to advanced stage at diagnosis. As one component of a study of the entire journey of SSA women with BC, we aimed to identify shared and setting-specific drivers of advanced stage BC. Women newly diagnosed in the multicountry African Breast Cancer-Disparities in Outcomes (ABC-DO) study completed a baseline interview and their stage information was extracted from medical records. Ordinal logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for advanced stage (I, II, III, IV) in relation to individual woman-level, referral and biological factors. A total of 1795 women were included from Nigeria, Uganda, Zambia, and the multiracial populations of Namibia and South Africa, 1091 of whom (61%) were stage III/IV. Stage was lower in women with greater BC knowledge (OR 0.77 (95% CI: 0.70, 0.85) per point on a 6 point scale). More advanced stage was associated with being black (4.00 (2.79, 5.74)), having attended <secondary education (1.75 (1.42, 2.16)), having never heard of BC (1.64 (1.31, 2.06)), an unskilled job (1.77 (1.43, 2.20)) and pregnancy in the past 3 years (30% of ≤45 year olds) (1.63 (1.15, 2.31)), and were mediated through delays to diagnosis: symptom duration of ≥ 1 year (OR 2.47 (1.93, 3.15)). These findings provide further evidence that late-stage BC in SSA is largely attributed to modifiable factors and strategies to improve BC education and awareness in women and the health system should be intensified.

Indexed as

AfricaBreast NeoplasmsFemaleHealth Services AccessibilityHumansLogistic ModelsMiddle AgedNeoplasm StagingOdds RatioPopulation GroupsProspective StudiesReferral and Consultationbreast cancerstage at diagnosissub-Saharan Africasurvival

Identifiers

PMID29197068
PMCPMC5838525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.